Implementation Strategies to Promote Equitable Dissemination of Long-Acting injectable PrEP to Black/Latino MSM and Transgender Women in Los Angeles
促进向洛杉矶黑人/拉丁裔 MSM 和跨性别女性公平传播长效注射剂 PrEP 的实施策略
基本信息
- 批准号:10602050
- 负责人:
- 金额:$ 24.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-30 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAddressAdoptionAffectAwarenessBlack PopulationsBlack raceCitiesCollaborationsCommunitiesCountyDataDevelopmentDiffusionDissemination and ImplementationEducational workshopEpidemicExploration Preparation Implementation and SustainmentFocus GroupsGaysGoalsHIVHIV InfectionsHIV diagnosisHIV/STDInjectableKnowledgeLatinaLatinoLettersLos AngelesOutcomePhasePopulationPopulations at RiskPreparationPreventionProviderPublic HealthResourcesRiskSeriesSexual and Gender MinoritiesTrustUnited States Food and Drug AdministrationWorkcommunity involvementexperiencegender minority grouphealth disparityimplementation frameworkimplementation strategyinnovationmembermenmen who have sex with menpre-exposure prophylaxispreventprevention serviceprogramsracial and ethnicscale upservice providerssextailored messagingtooltransgender womentreatment servicestrend
项目摘要
PROJECT ABSTRACT: HIV disproportionately affects Black and Latino men who have sex with men
and transgender women (BLMSM/TGW). These populations would greatly benefit from early access
to new HIV prevention tools. Recently, the Food and Drug Administration approved Apretude (an
extended-release injectable form of cabotegravir) for use as long-acting injectable pre-exposure
prophylaxis (LAI PrEP) to reduce the risk of acquiring HIV through sex. The equitable dissemination
of LAI PrEP to BLMSM/TGW can help decrease new HIV infections in these populations.
Unfortunately, historically these populations have lagged behind more privileged, well-resourced,
White gay men in receiving information about the newest HIV prevention options and the means of
accessing them to benefit from early adoption. As such, the goal of this project is to work within the
“Exploration and Preparation” phases of the Exploration, Preparation, Implementation, Sustainment
(EPIS) implementation framework to implement strategies to promote the equitable dissemination of
LAI PrEP among BLMSM/TGW in Los Angeles County (LAC). This project focuses on the Prevent
pillar of the national Ending the HIV Epidemic initiative and aligns with LAC’s EHE plan to facilitate
PrEP scale up efforts and reduce barriers to access and continuation. The project has three specific
aims. Aims 1 and 2 are to increase awareness and knowledge of, and trust and confidence in, LAI
PrEP as a new HIV prevention option among BLMSM/TGW and providers serving them. Aim 3 is to
develop a LAI PrEP strategic messaging guide to support ongoing diffusion of LAI PrEP information
by the LAC Public Health Department’s Division of HIV and STD Programs and BLMSM/TGW service
providers to facilitate greater community awareness and stimulate community discourse about the
use of this new HIV prevention tool among BLMSM/TGW in LAC. To achieve aims 1 and 2, we will
use a community-engaged approach to develop a series of informational/ educational community
workshops (n = 7) that prioritize and preemptively build service provider and consumer awareness,
knowledge, and confidence in LAI PrEP as an acceptable HIV prevention option for BLMSM/TGW in
LAC. To complete aim 3, we will conduct focus groups (n = 6) with BLMSM/TGW to inform the
development of a LAI PrEP strategic messaging guide of community-developed, culturally appropriate
messaging. The expected outcome of the project is creating greater community awareness, trust, and
confidence in LAI PrEP as a HIV prevention option for BLMSM/TGW among both consumers and
service providers. The anticipated impact of the project is a more equitable dissemination and
implementation of LAI PrEP among at-risk BLMSM/TGW heavily burdened by HIV in LAC.
项目摘要:艾滋病毒对与男性发生性行为的黑人和拉丁裔男性的影响不成比例
和变性人妇女(BLMSM/TGW)。这些人口将极大地受益于及早获得
到新的艾滋病毒预防工具。最近,美国食品和药物管理局批准了Apreude(An
卡波替格韦缓释注射剂型),用作长效注射用预暴露
预防(Lai PrEP),以降低通过性行为感染艾滋病毒的风险。公平分配
将LAI PrEP改为BLMSM/TGW有助于减少这些人群中新的艾滋病毒感染。
不幸的是,从历史上看,这些人口一直落后于更有特权、资源丰富、
白人男同性恋者获得有关最新艾滋病毒预防选择和手段的信息
访问它们以从早期采用中受益。因此,该项目的目标是在
探索、准备、实施、持续的“探索和准备”阶段
(EPIS)执行战略,以促进公平传播
洛杉矶县(LAC)BLMSM/TGW中的Lai PrEP。这个项目的重点是预防
国家终止艾滋病毒流行倡议的支柱,并与拉丁美洲和加勒比经济、社会和文化组织的计划保持一致,以促进
Prep加大努力,减少获取和继续的障碍。该项目有三个具体的
目标。目标一和目标二是增加对赖的认识和了解,以及对赖的信任和信心
在BLMSM/TGW和为他们提供服务的提供者中,PREP成为一种新的艾滋病毒预防选择。目标3是
制定LAI PrEP战略消息传送指南,以支持LAI PrEP信息的持续传播
由拉丁美洲和加勒比公共卫生部艾滋病毒和性传播疾病规划和BLMSM/TGW服务司提供
供应商,以促进更多的社区意识和刺激社区讨论
这一新的艾滋病毒预防工具在拉丁美洲和加勒比地区的青壮年和青壮年妇女中使用。为了实现目标1和目标2,我们将
使用社区参与的方法来开发一系列信息/教育社区
研讨会(n=7),优先并先发制人地建立服务提供商和消费者的意识,
对Lai PrEP作为#年BLMSM/TGW可接受的HIV预防选择的知识和信心
乳胶。为了完成目标3,我们将与BLMSM/TGW进行焦点小组(n=6),以告知
制定社区发展的、符合文化需要的LAI PrEP战略信息指南
消息传递。该项目的预期结果是创建更多的社区意识、信任和
消费者和妇女对Lai PrEP作为BLMSM/TGW艾滋病毒预防选择的信心
服务提供商。该项目的预期影响是更公平地传播和
在拉丁美洲和加勒比地区艾滋病毒负担沉重的高危BLMSM/TGW中实施LAI PrEP。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronald Andrew Brooks其他文献
Ronald Andrew Brooks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronald Andrew Brooks', 18)}}的其他基金
Evaluating the Feasibility and Acceptability of a Latino MSM Focused PrEP Uptake Intervention
评估以拉丁裔 MSM 为重点的 PrEP 摄取干预措施的可行性和可接受性
- 批准号:
10456315 - 财政年份:2020
- 资助金额:
$ 24.55万 - 项目类别:
Evaluating the Feasibility and Acceptability of a Latino MSM Focused PrEP Uptake Intervention
评估以拉丁裔 MSM 为重点的 PrEP 摄取干预措施的可行性和可接受性
- 批准号:
10239232 - 财政年份:2020
- 资助金额:
$ 24.55万 - 项目类别:
Evaluating the Feasibility and Acceptability of a Latino MSM Focused PrEP Uptake Intervention
评估以拉丁裔 MSM 为重点的 PrEP 摄取干预措施的可行性和可接受性
- 批准号:
10083014 - 财政年份:2020
- 资助金额:
$ 24.55万 - 项目类别:
The Influence of PrEP Stigma among Black and Latino MSM PrEP Adopters
PrEP 耻辱对黑人和拉丁裔 MSM PrEP 采用者的影响
- 批准号:
9266828 - 财政年份:2016
- 资助金额:
$ 24.55万 - 项目类别:
Center for HIV Identification, Prevention and Treatment Services (CHIPTS) - EHE Supp: Developing Implementation Strategies to Optimize PrEP Delivery to Immigrant Latino MSM in Los Angeles County
HIV 识别、预防和治疗服务中心 (CHIPTS) - EHE Supp:制定实施策略以优化洛杉矶县拉丁裔移民 MSM 的 PrEP 服务
- 批准号:
10395188 - 财政年份:1997
- 资助金额:
$ 24.55万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 24.55万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 24.55万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 24.55万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 24.55万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 24.55万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 24.55万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 24.55万 - 项目类别:














{{item.name}}会员




